Data Integrity: FDA/EMA/TGA Requirements and Implementation - 2-Day In-Person Seminar by Ex-FDA Director (Sydney, Australia - May 18-19, 2017) - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Data Integrity: FDA/EMA/TGA Requirements and Implementation: 2-Day In-Person Seminar by Ex-FDA Director" conference to their offering.

The FDA, EMA, TGA and others have published guidelines setting forth their requirements and expectations for the maintenance of data integrity, as has at least one leading industry organization (PDA).

The use of computer systems in virtually every aspect of data acquisition, storage, and analysis can help preserve data integrity and reduce or eliminate many errors, but the same technology can also create unique problems that must be prevented and managed.

In this two day workshop conference you will learn the meaning of "data integrity"; be exposed to some of the history that influences current regulatory requirements and expectations; see a comparison of the current guidance from leading regulatory agencies including the FDA, EMA, TGA and key industry associations such as the Parenteral Drug Association; see a recap of the enforcement options available to the FDA, including imposition of the Application Integrity Policy (also known as the "Fraud Policy"); discuss and learn from selected current real-life case histories; and hear advice for how to prevent, detect and react to data integrity problems so as to minimize business and regulatory risk.

Learning Objectives:

- Understand the meaning of the term data integrity and the importance of the acronym A.L.C.O.A. to regulatory agencies

- Understand the difference between innocent lapses and deliberate wrongful conduct

- Be aware of some of the key historical events that form the basis for regulators' concerns about data integrity

- Understand some of the common motivations for deliberate wrongful conduct that results in data falsification

- Understand the impact of the use of computer systems on the maintenance of data integrity, and what types of system controls are mandated by various agencies around the world

- Be aware of the possible business and regulatory consequences of noncompliance

- Understand the important steps to take to prevent, detect and react to data integrity problems

Who Should Attend:

- Senior Quality and Regulatory Affairs managers

- Clinical and Manufacturing Quality professionals

- Regulatory Affairs professionals

- Compliance professionals

- In House Legal Counsel

- Production supervisors

- Manufacturing personnel

- Production personnel

- Laboratory Managers

- Clinical Operations Personnel

- Drug Safety (Pharmacovigilance) Personnel

- R&D and Quality Control Scientists

- Quality auditors

For more information about this conference visit http://www.researchandmarkets.com/research/246xm8/data_integrity

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceutical Manufacturing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceutical Manufacturing